Iswekile yeglucosamine

Umxholo

• Kusenokwenzeka ukuba iyasebenza ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

IGlucosamine yimichiza eyenzeka ngokwendalo efumaneka emzimbeni womntu. Kukulwelo olujikeleze amalungu. I-Glucosamine ikwakhona nakwezinye iindawo kwindalo. Umzekelo, i-glucosamine esetyenziswa kwizongezo zokutya ihlala ifumaneka kwiigobolondo ze-shellfish. I-Glucosamine inokwenziwa kwilabhoratri.

Kukho iindlela ezahlukeneyo zeglucosamine kubandakanya i-glucosamine sulphate, i-glucosamine hydrochloride, kunye ne-N-acetyl glucosamine. Ezi khemikhali zahlukeneyo zinokufana, kodwa azinakuba neziphumo ezifanayo xa zithathwa njengesongezelelo sokutya. Uninzi lophando lwezenzululwazi kwi-glucosamine lubandakanye i-glucosamine sulphate.

Ezinye iimveliso ze-glucosamine azibhalwanga ngokuchanekileyo. Ngamanye amaxesha, isixa se-glucosamine kwimveliso siye sahluka ukusuka kwesinye ukuya ngaphezulu kwe-100% yemali echazwe kwileyibhile yemveliso. Ezinye iimveliso zine-glucosamine hydrochloride xa i-glucosamine sulphate yadweliswa kwileyibhile.

I-Glucosamine sulphate kunye ne-glucosamine hydrochloride ixhaphake kakhulu kwi-osteoarthritis. I-Glucosamine ikwasetyenziselwa ezinye iimeko ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe IGLUCOSAMINE zezi zilandelayo:

Kusenokwenzeka ukuba iyasebenza ...

• Osteoarthritis. Uninzi lophando lubonisa ukuba ukuthatha i-glucosamine sulphate kunokubonelela ngentlungu kubantu abane-osteoarthritis, ngakumbi abo bane-osteoarthritis emadolweni. Abanye abantu, i-glucosamine sulfate inokusebenza kunye ne-over-the-counter kunye neyeza zonyango njengemithi ye-acetaminophen okanye ibuprofen. Kodwa amayeza eentlungu asebenza ngokukhawuleza, ngelixa i-glucosamine sulphate inokuthatha iiveki ezi-4 ukuya kwezi-8 ngaphambi kokuba ibonelele ngesiqabu. Kananjalo, abantu abathatha i-glucosamine sulfate bahlala befuna ukuthatha amayeza eentlungu kwiintlungu.
  
  Kukho iintlobo ezininzi zeemveliso ze-glucosamine. Olu phando lubonisa esona sibonelelo seemveliso ziqulathe i-glucosamine sulfate. Iimveliso eziqulathe i-glucosamine hydrochloride ibonakala ingasebenzi ngaphandle kokuba zithathwa ngokudibanisa nezinye izithako. Iimveliso ezininzi ziqulathe i-glucosamine ene-chondroitin, kodwa abukho ubungqina obubambekayo bokuba ezi mveliso zisebenza ngokungcono kune-glucosamine sulfate ngokwayo.
  
  I-Glucosamine sulfate ibonakala ngathi ayithinteli abantu ekubeni bafumane i-osteoarthritis.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Intlungu edibeneyo ebangelwa ngamachiza abizwa ngokuba yiaromatase inhibitors (aromatase inhibitor-induction arthralgias). Uphando lwakwangoko lubonisa ukuba ukuthatha indibaniselwano ye-glucosamine sulphate kunye ne-chondroitin sulphate kwiidosi ezimbini okanye ezintathu ezahluliweyo mihla le kwiiveki ezingama-24 kunciphisa iintlungu kubafazi abathatha iziyobisi ezinciphisa amanqanaba e-estrogen kumhlaza webele.
• Isifo sentliziyo. Abantu abathatha i-glucosamine banokuba nomngcipheko ophantsi wokuhlaselwa sisifo sentliziyo. Kodwa akucaci ukuba yeyiphi idosi okanye uhlobo lweglucosamine enokusebenza ngcono. Akukacaci nokuba lo mngcipheko usezantsi uvela kwi-glucosamine okanye ekulandeleni imikhwa yokuphila esempilweni.
• Uxinzelelo. Uphando lwakwangoko lubonisa ukuba ukuthatha i-glucosamine hydrochloride kwiiveki ezi-4 kunokuphucula iimpawu zokudakumba kwabanye abantu abanexinzelelo.
• Seswekile. Abantu abathatha i-glucosamine banokuba nomngcipheko ophantsi wokuba nesifo seswekile. Kodwa akucaci ukuba yeyiphi idosi okanye uhlobo lweglucosamine enokusebenza ngcono. Akukacaci nokuba lo mngcipheko usezantsi uvela kwi-glucosamine okanye ekulandeleni imikhwa yokuphila esempilweni.
• Amanqanaba aphezulu e-cholesterol okanye amanye amafutha (lipids) egazini (hyperlipidemia). Uphando lwakwangoko lubonisa ukuba i-glucosamine hydrochloride ayichaphazeli i-cholesterol okanye amanqanaba e-triglyceride kubantu abane-cholesterol ephezulu.
• Ukuvuvukala kwexesha elide (ukuvuvukala) kwindawo yokugaya (isifo sesisu okanye isifo se-IBD). Kukho ubungqina bokuqala bokuba i-N-acetyl glucosamine ethathwe ngomlomo okanye ngokuthe ngcembe inokunciphisa iimpawu ze-IBD kubantwana abanesifo seCrohn okanye isifo sezilonda.
• Ukuphazamiseka okuchaphazela amathambo kunye namalungu, ihlala inabantu abanesiphene se-selenium (isifo seKashin-Beck). Ubungqina bokuqala bubonisa ukuba ukuthatha i-glucosamine hydrochloride kunye ne-chondroitin sulfate kunciphisa iintlungu kwaye kuphucula ukusebenza komzimba kubantu abadala abanale meko. Ukuthatha i-glucosamine hydrochloride yodwa kunokusebenza kunye neyeza zonyango.
• Intlungu yedolo. Uphando lwakwangoko lubonisa ukuba ukuthatha i-1500 mg yeglucosamine sulfate yonke imihla kwiintsuku ezingama-28 ayinciphisi iintlungu zamadolo kwiimbaleki ezilandela ukwenzakala emadolweni. Kodwa kubonakala ngathi kuphucula ukuhamba kwamadolo. Kukho ubungqina bokuqala bokuba i-glucosamine hydrochloride inokunciphisa iintlungu kwabanye abantu abaneentlungu ezixhaphakileyo emadolweni.
• Multiple sclerosis (MS). Uphando lwakwangoko lubonisa ukuba ukuthatha i-glucosamine sulphate ngomlomo yonke imihla kangangeenyanga ezi-6 kunokunciphisa ukubuyela kwakhona kwi-multiple sclerosis.
• Ukuchacha emva kotyando. Uphando lwakwangoko lubonisa ukuba ukuthatha i-glucosamine sulphate akuphuculi ukusebenza, iintlungu, kunye nokusebenza kweembaleki ezingamadoda ezazenziwe utyando ukulungisa i-ACL eqhekekileyo. I-ACL ligament ebambe idolo endaweni yokuhamba.
• Isifo samathambo (RA). Uphando lwakwangoko lubonisa ukuba ukuthatha i-glucosamine hydrochloride kunokunciphisa iintlungu kodwa hayi inani lokudumba nelibuhlungu kwamalungu.
• Ukubetha. Uphando lwakwangoko lufumanise ukuba abantu abathatha i-glucosamine banokuba semngciphekweni omncinci wokuba ne-stroke. Kodwa akucaci ukuba yeyiphi idosi okanye uhlobo lweglucosamine enokusebenza ngcono. Kodwa akucaci ukuba lo mngcipheko usezantsi uvela kwi-glucosamine okanye kwindlela yokuphila esempilweni.
• Iqela leemeko ezibuhlungu ezichaphazela ukudibana kwemihlathi kunye nezihlunu (iingxaki zetemporomandibular okanye i-TMD). Uphando lwakwangoko aluvumelani nokuba i-glucosamine sulphate iyazinciphisa na iintlungu kubantu abane-osteoarthritis yedibeneyo yomhlathi.
• Ulusu olugugileyo.
• Umqolo obuhlungu.
• Ukukhula okungenawo umhlaza emathunjini amakhulu kunye ne-rectum (i-colorectal adenoma).
• Ukufa nangasiphi na isizathu.
• Intlungu edibeneyo.
• Isifo esibuhlungu sesinyi (Interstitial cystitis).
• Ukuphilisa amanxeba.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala i-glucosamine sulphate kwezi zinto zisetyenziswayo.

I-Glucosamine yikhemikhali efumaneka emzimbeni womntu. Isetyenziswe ngumzimba ukuvelisa ezinye iikhemikhali ezichaphazelekayo ekwakheni imisipha, iigaments, i-cartilage, kunye nolwelo olunamandla olujikeleze amalungu.

Amalungu adityaniswa lulwelo kunye nentlala ebajikelezileyo. Kwabanye abantu abane-osteoarthritis, i-cartilage iphuka kwaye iyancipha. Oku kubangela ukungqubana ngokudibeneyo, iintlungu kunye nokuqina. Abaphandi bacinga ukuba ukuthatha izongezo ze-glucosamine kunokunyusa i-cartilage kunye ne-fluid ejikeleze amalungu okanye kuncede ukuthintela ukonakala kwezi zinto, okanye mhlawumbi zombini.

Xa kuthathwa ngomlomo: Iswekile yeglucosamine is NGOKUKHUSELEKILEYO kuninzi lwabantu abadala. Glucosamine hydrochloride yi UKHUSELEKO OLUNOKWENZEKA kubantu abadala abaninzi xa bethathwe ngokufanelekileyo ukuya kuthi ga kwiminyaka emibini. N-acetyl glucosamine nayo UKHUSELEKO OLUNOKWENZEKA xa ithathwa kumthamo we-3-6 yeegram mihla le. I-Glucosamine inokubangela ezinye iziphumo ebezingalindelekanga ezinobumnene kubandakanya isicaphucaphu, ukubetha kwentliziyo, urhudo kunye nokuqunjelwa. Iziphumo ebezingalindelekanga eziqhelekileyo zikozela, ukusabela kolusu kunye nentloko.

Xa isetyenziswa eluswini: I-acetyl glucosamine yiyo UKHUSELEKO OLUNOKWENZEKA xa isetyenzisiwe ukuya kuthi ga kwiiveki ezili-10.

Xa unikwa njenge-enema (ngokuthe ngqo): I-acetyl glucosamine yiyo UKHUSELEKO OLUNOKWENZEKA xa isetyenziswe kumanani e-3-4 gram imihla ngemihla.

Xa unikezwe ngokudutyulwa: Iswekile yeGlucosamine UKHUSELEKO OLUNOKWENZEKA xa utofelwe kwimisipha njengefoto kabini ngeveki ukuya kuthi ga kwiiveki ezi-6.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa okanye ukuncancisa: Akukho lwazi lwaneleyo lwanokuthenjwa lokwazi ukuba ngaba i-glucosamine sulphate, i-glucosamine hydrochloride, okanye i-N-acetyl glucosamine ikhuselekile ukuba ingasetyenziswa xa ukhulelwe okanye uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Isifo sombefu: Kukho ingxelo enye edibanisa uhlaselo lwesifuba kunye nokuthatha i-glucosamine. Ayaziwa ngokuqinisekileyo ukuba ngaba i-glucosamine yayingunobangela wokuhlaselwa sisifo sombefu. Kude kube kwaziwa ngakumbi, abantu abane-asthma kufuneka balumke malunga nokuthatha iimveliso eziqukethe i-glucosamine.

Seswekile: Olunye uphando lwaphambi kwexesha lwacebisa ukuba i-glucosamine inokuphakamisa iswekile yegazi kubantu abanesifo seswekile. Kodwa uphando olutshanje noluthembekileyo ngoku lubonisa ukuba i-glucosamine ayibonakali ichaphazela ukulawulwa kweswekile yegazi kubantu abane-2 yeswekile. I-Glucosamine ibonakala ikhuselekile kubantu abaninzi abanesifo seswekile, kodwa iswekile yegazi kufuneka ijongisiswe ngokusondeleyo.

Iglaucoma: I-Glucosamine inokunyusa uxinzelelo ngaphakathi kwiso kwaye iyenze glaucoma ibe mandundu. Ukuba une-glaucoma, thetha nomboneleli wakho wezempilo ngaphambi kokuba uthathe i-glucosamine.

Cholesterol ephezulu: Olunye uphando lwaphambi kwexesha lucebise ukuba i-glucosamine inokunyusa amanqanaba e-cholesterol. Kodwa uphando olutshanje noluthembekileyo ngoku lubonisa ukuba i-glucosamine ibonakala ngathi ayonyusi amanqanaba e-cholesterol.

Igazi elonyukayo: Olunye uphando lwaphambi kwexesha lucebise ukuba i-glucosamine inokunyusa amanqanaba e-insulin. Kodwa uphando olutshanje noluthembekileyo lubonisa ukuba i-glucosamine ayinyusi uxinzelelo lwegazi. Ukuze ube kwicala elikhuselekileyo, jonga uxinzelelo lwegazi ngokusondeleyo ukuba uthatha i-glucosamine sulphate kwaye unexinzelelo lwegazi.

Unyango lweShellfish: Kukho inkxalabo yokuba iimveliso ze-glucosamine zinokubangela ukungahambelani komzimba nabantu abanolwazelelelo kwi-shellfish. I-Glucosamine iveliswa kwiigobolondo ze-shrimp, i-lobster kunye noononkala. Ukuphazamiseka komzimba kubantu abane-shellfish yokungezwani komzimba kubangelwa yinyama ye-shellfish, hayi iqokobhe. Kodwa abanye abantu baye baqala ukuphendula emva kokusebenzisa izongezo ze-glucosamine. Kungenzeka ukuba ezinye iimveliso ze-glucosamine zinokungcoliseka yinxalenye yenyama yentlanzi enokubangela ukungalungelani. Ukuba une-allergies ye-shellfish, thetha nomboneleli wakho ngaphambi kokusebenzisa i-glucosamine.

Mkhulu

Sukuyithatha le indibaniselwano.

IWarfarin (Coumadin)

I-Warfarin isetyenziselwa ukunciphisa ukucinywa kwegazi. Kukho iingxelo ezininzi ezibonisa ukuba ukuthatha i-glucosamine kunye okanye ngaphandle kwe-chondroitin kunyusa ifuthe le-warfarin, lenze ukuba igazi lijiye kancinci kancinci. Oku kunokubangela ukugruzuka nokopha okunokuba kubi kakhulu. Musa ukuthatha i-glucosamine ukuba uthatha i-warfarin. Uninzi lwamayeza endalo anokusebenzisana ne-warfarin.

Iphakathi

Lumka ngale nhlanganisela.

Amayeza omhlaza (Topoisomerase II Inhibitors)

Amanye amayeza omsebenzi womhlaza ngokunciphisa indlela iiseli zomhlaza ezikhawulezayo ezinokuzikopa ngayo. Abanye oososayensi bacinga ukuba i-glucosamine inokuwathintela la mayeza ekunciphiseni ukuba iiseli zesisu ezinokukopa ngokukhawuleza kangakanani na. Ukuthatha i-glucosamine kunye namanye amayeza omhlaza kunokunciphisa ukusebenza kwala mayeza.

Amanye amayeza asetyenziselwa umhlaza afaka i-etoposide (VP16, VePesid), teniposide (VM26), mitoxantrone, daunorubicin, kunye doxorubicin (Adriamycin).

Incinci

Jonga olu dibaniso.

I-Acetaminophen (iTylenol, abanye)

Kukho inkxalabo yokuba ukuthatha i-glucosamine SULFATE kunye ne-acetaminophen (iTylenol, ezinye) ngokudibeneyo kunokuchaphazela ukusebenza kakuhle komntu ngamnye. Kodwa ulwazi oluthe kratya luyafuneka ukwazi ukuba le ntsebenzo yinkxalabo enkulu. Okwangoku, uninzi lweengcali zithi kulungile ukusebenzisa zombini ngokudibeneyo.

Amayeza eswekile (iziyobisi zeAntidiabetes)

Olunye uphando lwaphambi kwexesha lwacebisa ukuba i-glucosamine inokuphakamisa iswekile yegazi kubantu abanesifo seswekile. Kodwa uphando olutshanje noluthembekileyo ngoku lubonisa ukuba i-glucosamine ayibonakali ichaphazela ukulawulwa kweswekile yegazi kubantu abane-2 yeswekile. Ke ngoko, i-glucosamine ayiphazamisi kunyango lweswekile.

Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .

Chondroitin sulphate

Ukuthatha i-chondroitin sulfate kunye ne-glucosamine HYDROCHLORIDE kunokunciphisa amanqanaba egazi le-glucosamine. Kodwa akucaci ukuba oku kuyakutshintsha iziphumo ze-glucosamine hydrochloride.

Akukho kunxibelelana kwaziwayo nokutya.

La machiza alandelayo afundwe kuphando lwezesayensi:

NGOMLOMO:

• Kwi-osteoarthritisI-Glucosamine SULFATE 1500 mg kanye yonke imihla okanye i-500 mg kathathu yonke imihla, nokuba iyodwa okanye kunye ne-400 mg ye-chondroitin sulphate kabini okanye kathathu ngemini, isetyenzisiwe ukuya kuthi ga kwiminyaka emi-3.

(3R, 4R, 5S, 6R) -3-Amino-6- (Hydroxymethyl) I-Oxane-2,4,5-Triol Hydrochloride, 2-Amino-2-Deoxy-Glucose, 2-Amino-2-Deoxy-Beta- D-Glucopyranose, 2-Amino-2-Deoxy-D-Glucose Sulfate, Acetylglucosamine, Acétylglucosamine, GlcNAc, 3-Amino-6- (Hydroxymethyl) Oxane-2,4,5-Triol Sulfate, Amino Monosaccharide, Chitosamine, Chlorhidrato Glucosamina, Chlorhydrate de Glucosamine, Chlorure de Potassium-Sulfate de Glucosamine, D-Glucosamine, D-Glucosamine HCl, D-Glucosamine Sulfate, D-Glucosamine Sulphate, G6S, Glucosamine HCl, Glucosamine KCl, Glucosamine yeGlucosamine I-Sulphate, iGlucosamine Sulfate 2KCl, iGlucosamine Sulfate-Potassium Chloride, iGlucosamine Sulphate, iGlucosamine Sulphate KCl, iGlucosamine-6-Phosphate, GS, Mono-Sulfated Saccharide, N-Acetil Glucosamina, N-Ac-Acl Netyamine yeGlucosamine. I-Acétylglucosamine, N-Acetyl D-Glucosamine, N-Acétyl D-Glucosamine, NAG, pGlcNAc, Poly-N-Acetyl Glucosamine, Poly-NAG, Poly- (1-> 3) -N-Acetyl-2-Amino-2- I-Deoxy-3-O-Beta-D-Gl ucopyranurosyl-4- (okanye 6-) Sul, p-GlcNAc, Saccharide Mono-Sulfate, Saccharide Sulfate, Sulfate de Glucosamine, Sulfate de Glucosamine 2KCl, SG, Sulfated Monosaccharide, Sulfated Saccharide, Sulfato de Glucosamina. I-2-Amino-2-Deoxy-D-Glucosehydrochloride, 2-Amino-2-Deoxy-Beta-D-Glucopyranose, 2-Amino-2-Deoxy-Beta-D-Glucopyranose Hydrochloride, Amino Monosaccharide, Chitosamine Hydrochloride, Chlorlucidina , Chlorhydrate de Glucosamine, D-Glucosamine HCl, D-Glucosamine Hydrochloride, Glucosamine, Glucosamine HCl, Glucosamine KCl, Glucosamine-6-Phosphate. 2-Acetamido-2-deoxyglucose, Glucosamine, Glucosamine-6-phosphate, Glucosamine N-Acetyl, N-Acetil Glucosamina, N-Acétyl Glucosamine, N-Acétyl-Glucosamine, N-Acétylglucosamine, N-Acetyl D-Glucosamine I-Acétyl D-Glucosamine, NAG, NAG, pGlcNAc, Poly-N-Acetyl Glucosamine, Poly-NAG, p-GlcNAc.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UKumkani u-DE, u-Xiang J. Glucosamine / uChondroitin kunye nokufa kwabantu kwi-US NHANES Cohort. J NdiyiBhodi Fam Med. Ngo-2020; 33: 842-847. Jonga i-abstract.
2. ULee DH, uCao C, uZong X, et al. I-Glucosamine kunye neChondroitin Supplements kunye neRisk yeColorectal Adenoma kunye neSerrated Polyp. Umhlaza we-Epidemiol Biomarkers ezidlulileyo. NgoNovemba 2020; 29: 2693-2701. Jonga i-abstract.
3. I-Kumar PNS, i-Sharma A, ne-Andrade C. Umqhubi wenqwelomoya, uphando lweelebheli ezivulekileyo malunga nokusebenza kweglucosamine kunyango loxinzelelo olukhulu. U-Asia J Psychiatr. 2020; 52: 102113. Jonga i-abstract.
4. UMa H, uLi X, uZhou T, et al. Ukusetyenziswa kweGlucosamine, ukudumba, kunye nokuchaphazeleka kofuzo, kunye neziganeko zohlobo lweswekile yesi-2: isifundo esinokwenzeka e-UK Biobank. Unonophelo lweSwekile. Ngo-2020; 43: 719-25. Jonga i-abstract.
5. UBruyere O, Honvo G, uVeronese N, et al. Ingcebiso ehlaziyiweyo ye-algorithm yokulawulwa kwamadolo e-osteoarthritis kuMbutho waseYurophu woNyango lwezoNyango kunye nezoQoqosho lweOsteoporosis, Osteoarthritis, kunye neMisculoskeletal Disease (ESCEO). Isemina iRheum yeArthritis. NgoDisemba ka-2019; 49: 337-50. Jonga i-abstract.
6. I-Navarro SL, umrhumo L, uCurtis KR, uLampe JW, uHullar MAJ. Ukumodareyithwa kweGut Microbiota yiGlucosamine kunye neChondroitin kuLingo oluQhelekileyo, oluMfama oLungeloukuBala ebantwini. Amagciwane. 2019 Novemba 23; 7. IPH: E610. Jonga i-abstract.
7. Ukugcina i-OF, Finamore R, Stellavato A, et al. I-chondroitin sulphate yaseYurophu kunye neglucosamine yokutya: Umgangatho wenkqubo kunye novavanyo lobungakanani xa kuthelekiswa namayeza. ICarhydr Polym. 2019 Oktobha 15; 222: 114984. Jonga i-abstract.
8. IHoban C, u-Byard R, u-Musgrave I. Ukuphendula gwenxa kweziyobisi kwi-glucosamine kunye namalungiselelo e-chondroitin e-Australia phakathi kwe-2000 kunye ne-2011. I-Postgrad Med J. 2019 Oct 9. pii: postgradmedj-2019-136957. Jonga i-abstract.
9. IKolasinski SL, uNeogi T, iHochberg MC, et al. I-2019 American College yeRheumatology / Isiseko seArthritis Isikhokelo solawulo lwe-osteoarthritis yesandla, inyonga, kunye nedolo. Isifo samathambo Rheumatol. NgoFebruwari 2020; 72: 220-33. Jonga i-abstract.
10. I-Tsuruta A, Horiike T, Yoshimura M, Nagaoka I. Uvavanyo lwesiphumo solawulo lwe-glucosamine equlathe isongezelelo kwii-biomarkers ze-cartilage metabolism kubadlali bebhola ekhatywayo: Isifundo esilawulwa ngokungahleliwe. Mol Mol Rep. 2018 Okt; 18: 3941-3948. Epub 2018 Aug 17. Jonga i-abstract.
11. Efanayo-Mendía M, Sánchez-García A, Vilchez-Cavazos F, Acosta-Olivo CA, Peña-Martínez VM, Simental-Mendía LE. Iziphumo ze-glucosamine kunye ne-chondroitin sulfate kwiimpawu zedolo le-osteoarthritis: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta lwezilingo ezilawulwa ngokungenamthetho. IRheumatol Int. 2018 Agasti; 38: 1413-1428. Epub 2018 Jun 11. Ukuphononongwa. Jonga i-abstract.
12. UGregori D, uGiacovelli G, uMinto C, et al. Umbutho woNyango lwezeMithi kunye noLawulo lwePhepha lwexesha elide kwizigulana ezine-Knee Osteoarthritis: Ukuphononongwa ngokuCwangcisiweyo kunye nohlalutyo lweMeta. JAMA. Ngo-2018 uDisemba 25; 320: 2564-2579. Jonga i-abstract.
13. U-Ogata T, u-Ideno Y, u-Akai M, et al. Iziphumo ze-glucosamine kwizigulana ezine-osteoarthritis emadolweni: uphononongo lwenkqubo kunye nohlalutyo lweemeta. KwiKlinikhi yaseRheumatol. 2018 Sep; 37: 2479-2487. Epub 2018 Epreli 30. Jonga i-abstract.
14. Ma H, Li X, Ilanga D, et al. Umbutho wokusetyenziswa kwesiqhelo kweglucosamine ngomngcipheko wesifo sentliziyo: isifundo esinokwenzeka e-UK Biobank. BMJ. 2019 ngoMeyi 14; 365: l1628. Jonga i-abstract.
15. I-Vos BC, iLungu leLandmeer MLA, van Middelkoop M, et al. Iziphumo zexesha elide zongenelelo ngendlela yokuphila kunye nomlomo we-glucosamine sulphate kukhathalelo lokuqala kwiziganeko zeedolo OA kubafazi abagqithisileyo. IRheumatology (iOxford). Ngo-2017; 56: 1326-1334. Jonga i-abstract.
16. I-Tsuji T, Yoon J, Kitano N, Okura T, Tanaka K. Iziphumo ze-N-acetyl glucosamine kunye ne-chondroitin sulphate yongezelelo kwiintlungu zamadolo kunye nokuzichaza ngokwakho emadolweni kubantu abadala baseJapan nabadala: i-randomized, double-blind, Uvavanyo olulawulwa yi-placebo. Ukwaluphala kwiKlinikhi yokuDala. Ngo-2016; 28: 197-205. Jonga i-abstract.
17. U-Runhaar J, uDeroisy R, u-van Middelkoop M, kunye no-al. Indima yokutya kunye nokuzilolonga kunye ne-glucosamine sulphate kuthintelo lwe-osteoarthritis: Iziphumo ezongezelelekileyo ezivela kuthintelo lwamadolo e-Osteoarthritis kwisifundo se-Overweight Females (PROOF). Isemina iRheum yeArthritis. Ngo-2016; 45 (4 iSuppl): S42-8. Jonga i-abstract.
18. I-Roman-Blas JA, i-Castañeda S, iSánchez-Pernaute O, et al. Ukuchaneka Unyango oluHlanganisiweyo kunye neChondroitin Sulfate kunye neGlucosamine Sulfate ayibonisi bume bungaphezulu kwePlacebo yokuNcitshiswa kweNtlungu eHlanganisiweyo kunye nokuSebenza okuSebenzayo kwizigulana ezine-Knee Osteoarthritis: Iinyanga eziNtandathu zeMulticenter, iRandomised, Double-Blind, Placebo-Controlled Clinical Trial. Isifo samathambo Rheumatol. Ngo-2017; 69: 77-85. Jonga i-abstract.
19. Kongtharvonskul J, Anothaisintawee T, McEvoy M, Attia J, Woratanarat P, Thakkinstian A. Ukusebenza kunye nokukhuseleka kweglucosamine, diacerein, kunye neeNSAID emadolweni e-osteoarthritis: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zenethiwekhi. I-Eur J Med Res. Ngo-2015; 20: 24. Jonga i-abstract.
20. I-Kanzaki N, i-Ono Y, i-Shibata H, i-Moritani T.I-Glucosamine ene-supplement ephucula imisebenzi ye-locomotor kwizifundo ezinentlungu yamadolo: isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. Ukwaluphala kwaKlinikhi. Ngo-2015; 10: 1743-53. Jonga i-abstract.
21. UGueniche A, uCastiel-Higounenc I. Ukusebenza kweGlucosamine Sulphate kulusu lokuDala: Iziphumo ezivela kwi-ex vivo yeModeli yokuGuga nokuLingwa kweKlinikhi. Ulusu Pharmacol Physiol. Ngo-2017; 30: 36-41. Jonga i-abstract.
22. I-Eraslan A, i-Ulkar B.I-Glucosamine yokuncedisa emva kokuphinda kwakhiwe umgudu wokwakha ngokutsha iimbaleki kwiimbaleki: ityala elilawulwa ngokungenamthetho. Res Sports Med. Ngo-2015; 23: 14-26. Jonga i-abstract.
23. U-Esfandiari H, uPakravan M, uZakeri Z, et al. Iziphumo ze-glucosamine kuxinzelelo lwe-intraocular: uvavanyo lwezonyango olungenamsebenzi. Iliso. Ngo-2017; 31: 389-394.
24. UMurphy RK, uJaccoma EH, uRice Rice, uKetzler L.Glucosamine njengoMngcipheko oNokubakho weGlaucoma. Utyalomali lweOphthalmol Vis Sci 2009; 50: 5850.
25. U-Eriksen P, u-Bartels EM, u-Altman RD, u-Bliddal H, u-Juhl C, u-Christensen R. Umngcipheko wokhetho kunye ne-brand zichaza ukungangqinelani okuqwalaselwayo kwizilingo kwi-glucosamine yokufumana umqondiso we-osteoarthritis: uhlalutyo lwe-meta lovavanyo lwe-placebo. Ukunyamekelwa kweArthritis Res (Hoboken). Ngo-2014; 66: 1844-55. Jonga i-abstract.
26. USingh JA, uNorbaloochi S, uMacDonald R, uMaxwell LJ. I-Chondroitin ye-osteoarthritis. Isiseko sedatha yeCochrane Isityhi sika-2015 ngoJanuwari 28; 1: CD005614. Jonga i-abstract.
27. UBruyère O, Cooper C, uPelletier JP, et al. Isiteyitimenti sokuvumelana kwi-European Society ye-Clinical and Economic Aspects ye-Osteoporosis kunye ne-Osteoarthritis (ESCEO) algorithm yokulawulwa kwamadolo e-osteoarthritis-Ukusuka kumayeza asekwe kubungqina kubomi bokwenyani. Isemina iRheum yeArthritis. Ngo-2016; 45 (4 iSuppl): S3-11. Jonga i-abstract.
28. UKimball AB, uKaczvinsky JR, uLi J, et al. Ukuncitshiswa kwembonakalo yobuso bentsholongwane emva kokusetyenziswa kwezithambisi ngokudityaniswa kwe-niacinamide kunye ne-N-acetyl glucosamine: iziphumo zelingo elilawulwa ngokungahleliwe, elingaboniyo nelilawulwa yimoto. UBr J Dermatol 2010; 162: 435-41. Jonga i-abstract.
29. UMadhu K, uChanda K, uSaji MJ. Ukhuseleko kunye nokusebenza kweCurcuma longa isicatshulwa kunyango lwe-osteoarthritis yamadolo ebuhlungu: ulingo olulawulwa ngokungenamthetho. I-Inflammopharmacology 2013; 21: 129-36 (PubMed) (Umnqamlezo) Jonga i-abstract.
30. UVetter G. [Unyango lwezihloko ze-arthroses ezine-glucosamines (Dona 200)]. Ukutya iMed Wochenschr 1969; 111: 1499-502. Jonga i-abstract.
31. I-Setnikar I, i-Giacchetti C, i-Zanolo G. Pharmacokinetics ye-glucosamine kwinja nakwindoda. IArzneimittelforschung 1986; 36: 729-35. Jonga i-abstract.
32. I-Basak M, uJoseph S, uJoshi S, uSawant S. Ukuthelekiswa kokufumaneka kokuveliswa kwexesha kunye nokuqulunqwa kwe-glucosamine sulfate-powder-dose, i-randomized, i-crossover study. I-Int J Clin Pharmacol Ther 2004; 42: 597-601. Jonga i-abstract.
33. I-Phitak T, i-Pothacharoen P, i-Kongtawelert P. Ukuthelekiswa kweziphumo zeglucose kwi-cartilage degradation. I-BMC Musculoskelet Disord 2010; 11: 162. Jonga i-abstract.
34. I-Setnikar I, i-Cereda R, i-Pacini MA, ne-Revel L.Iipropathi ezingasebenziyo ze-glucosamine sulfate. IArzneimittelforschung 1991; 41: 157-61. Jonga i-abstract.
35. ISumantran VN, uChandwaskar R, uJoshi AK, uBoddul S, uPatwardhan B, uChopra A kunye no-Wagh UV. Ubudlelwane phakathi kwempembelelo ye-chondroprotective kunye ne-antiinflammatory ye-Andania somnifera ingcambu kunye ne-glucosamine sulphate kwi-osteoarthritic cartilage in vitro. UPhytother Res 2008; 22: 1342-8. Jonga i-abstract.
36. I-Setnikar I, i-Pacini MA, ne-Revel L.Iziphumo ze-antiarthritic ze-glucosamine sulfate efundwe kwiimodeli zezilwanyana. IArzneimittelforschung 1991; 41: 542-5. Jonga i-abstract.
37. UBassleer C, uHenrotin Y, uFranchimont P.Ukuvavanywa kwe-vitro yamachiza acetywayo njengeearhente ze-chondroprotective. I-Int J Tissue React 1992; 14: 231-41. Jonga i-abstract.
38. ICalamia V, uRuiz-Romero C, uRocha B, uFernández-Puente P, uMateos J, uMontell E, uVergés J, uBlanco FJ. Isifundo se-Pharmacoproteomic seziphumo ze-chondroitin kunye ne-glucosamine sulphate kwii-chondrocyte ze-articular zabantu. Isifo seArthritis Res Ther 2010; 12: R138. Jonga i-abstract.
39. IGraeser AC, Giller K, Wiegand H, Barella L, Boesch Saadatmandi C, Rimbach G. Synergistic chondroprotective isiphumo se-alpha-tocopherol, ascorbic acid, kunye ne-selenium kunye ne-glucosamine kunye ne-chondroitin kwi-oxidant eyenziweyo yokufa kweseli kunye nokuthintela i-matrix metalloproteinase-3 --izifundo kwii-chondrocyte ezikhulisiweyo. Iimolekyuli. Ngo-2009; 15: 27-39. Jonga i-abstract.
40. UMurphy RK, uKetzler L, uRice Rice, uJohnson SM, uDoss MS, uJaccoma EH. Isongezo somlomo se-glucosamine njengearhente yoxinzelelo lwegazi. IJAMA Ophthalmol 2013; 131: 955-7. Jonga i-abstract.
41. I-Swinburne LM. Iswekile yeglucosamine kunye neasteoarthritis. ILancet 2001; 357: 1617. Jonga i-abstract.
42. Akarasereenont P, Chatsiricharoenkul S, Pongnarin P, Sathirakul K, Kongpatanakul S.Bioequivalence Study of 500 mg glucosamine sulphate kumavolontiya asempilweni aseThai. UJ Med Assoc Thai 2009; 92: 1234-9. Jonga i-abstract.
43. Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK, Bichile L, Narsimulu G, Handa R, Patwardhan B. A Randomized Exploratory Exploratory of Standardised Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project Project . Ubungqina bokuSebenza ngokuGqibezela iMed 2011; 2011: 724291. Jonga i-abstract.
44. I-Wangroongsub Y, Tanavalee A, Wilairatana V, Ngarmukos S. Iziphumo ezinokuthelekiswa zeklinikhi phakathi kwe-glucosamine sulphate-potassium chloride kunye ne-glucosamine sulfate sodium chloride kwizigulana ezine-osteoarthritis yamadolo amnene kwaye aphakathi. UJ Med Assoc Thai 2010; 93: 805-11. Jonga i-abstract.
45. ISmidt D, iTorpet LA, iNauntofte B, iHeegaard KM, iPedersen AM. Unxibelelwano phakathi kwamanqanaba okuhamba kunye nokuhamba kwamathe, izifo zenkqubo kunye namayeza kwisampuli yabantu abadala. Uluntu lwaseDent Oral Epidemiol 2010; 38: 422-35. Jonga i-abstract.
46. USimon RR, uMarko V, uLeed Le, noAnderson JW. Uphengululo olubanzi lokusetyenziswa kweglucosamine yomlomo kunye nefuthe kwimetabolism yeglucose kubantu abaqhelekileyo nabanesifo seswekile. Isifo seswekile iMetab Res Rev 2011; 27: 14-27. Jonga i-abstract.
47. UWilkens, P., Scheel, I. B., Grundnes, O., Hellum, C., kunye noStorheim, K. Iziphumo ze-glucosamine kukhubazeko olunxulumene nentlungu kwizigulana ezinentlungu engapheliyo kunye ne-lumbar osteoarthritis: isilingo esilawulwa ngokungahleliwe. IJAMA 2010; 304: 45-52. Jonga i-abstract.
48. UGreenlee H, uCrew KD, uShao T, uKranwinkel G, uKalinsky K, uMaurer M, uBrafman L, u-Insel B, u-Tsai WY, uHershman DL. Isigaba sesi-II sokufunda nge-glucosamine ene-chondroitin kwi-aromatase inhibitor enxulumene neempawu zokudibana kwabasetyhini abanomhlaza wamabele. Inkxaso yoMhlaza woNyango 2013; 21: 1077-87. Jonga i-abstract.
49. I-Nieman DC, i-Shanely RA, i-Luo B, i-Dew D, i-MP ye-Meaney, i-Sha W. Isongezelelo sokutya esithengiswayo sinciphisa intlungu edibeneyo kubantu abadala: ityala elilawulwa yi-placebo. Isondlo J 2013; 12: 154. Jonga i-abstract.
50. UFransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, Jan S, Matshi L, Edmonds J, Norton R, Woodward M, Usuku R; Iqela le-LEGS lokufunda ngokubambisana. I-Glucosamine kunye ne-chondroitin yamadolo e-osteoarthritis: uvavanyo lweklinikhi olulawulwa ngokujonga ulwahlulo lwe-placebo kuvavanyo lweerimens enye kunye nokudibanisa. UAnn Rheum Dis 2015; 74: 851-8. Jonga i-abstract.
51. Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B. Amayeza e-Ayurvedic anika enye indlela efanelekileyo kwi-glucosamine kunye ne-celecoxib kunyango uphawu lweedolo osteoarthritis: ilingo elingenamsebenzi, elingaboniyo, elilawulwa ngokulingana kweziyobisi. IRheumatology (Oxford) 2013; 52: 1408-17. Jonga i-abstract.
52. ULevin RM, uKrieger NN, kunye noWinzler RJ. I-Glucosamine kunye nokunyamezelana kwe-acetylglucosamine emntwini. Ilebhu yeklinikhi yeMed 1961; 58: 927-932.
53. UWu H, uLiu M, uWang S, uZhao H, uYao W, uFeng W, uYan M, uTang Y, u-Wei M.Ukuthelekisa ukuzila ukutya kunye neempawu ze-pharmacokinetic ze-2 ukwenziwa kweglucosamine hydrochloride kumavolontiya amadala aseTshayina asempilweni. Iifayile. Ngo-2012 Agasti; 62: 367-71. Jonga i-abstract.
54. Liang CM, Tai MC, Chang YH, Chen YH, Chen CL, Chien MW, Chen JT. I-Glucosamine inqanda ukukhula kwe-epidermal factor-eyandisayo kunye nokuqhubela phambili komjikelo weseli kwiiseli ze-epithelial pigment retinal. I-Mol Vis 2010; 16: 2559-71. Jonga i-abstract.
55. I-Yomogida S, i-Hua J, i-Sakamoto K, i-Nagaoka I. I-Glucosamine icinezela imveliso ye-interleukin-8 kunye ne-ICAM-1 expression by TNF-alpha-stimulated human colonic epithelial HT-29 cells. I-Int J Mol Med 2008; 22: 205-11. Jonga i-abstract.
56. UKim CH, uCheong KA, iCD yePaki, uLee AY. I-Glucosamine iphucule i-atopic dermatitis-efana nolusu kwiimpuku ze-NC / Nga ngokuthintela ukukhula kweseli ye-Th2. IScand J Immunol 2011; 73: 536-45. Jonga i-abstract.
57. U-Y Y, u-Hua J, u-Sakamoto K, u-Ogawa H, u-Nagaoka I. I-Glucosamine, eyenzeka ngokwendalo ye-amino monosaccharide modulates LL-37-indased endothelial cell activation. I-Int J Mol Med 2008; 22: 657-62. Jonga i-abstract.
58. I-Qiu W, i-Su Q, i-Rutledge AC, i-Zhang J, i-Adeli K.I-Glucosamine-indened endoplasmic reticulum uxinzelelo ifumana i-apolipoprotein B100 synthesis ngokusayina kwe-PERK. J Lipid Res 2009; 50: 1814-23. Jonga i-abstract.
59. U-Y Y, u-Hua J, u-Sakamoto K, u-Ogawa H, u-Nagaoka I. Ukumodareyitha kwe-TNF-alpha-indased endothelial activation ye-glucosamine, eyenzeka ngokwendalo ye-amino monosaccharide. I-Int J Mol Med 2008; 22: 809-15. Jonga i-abstract.
60. Ilic MZ, uMartinac B, uSamiric T, uHandley CJ. Iziphumo ze-glucosamine kwilahleko ye-proteoglycan yitonon, ligament kunye ne-capsule edibeneyo yokuhlola inkcubeko. I-Osteoarthritis Cartilage 2008; 16: 1501-8. Jonga i-abstract.
61. I-Toegel S, i-Wu SQ, i-Piana C, i-Unger FM, i-Wirth M, i-Goldring MB, i-Gabor F, i-Viernstein H. Ukuthelekiswa phakathi kwe-chondroprotective ye-glucosamine, i-curcumin, kunye ne-diacerein kwi-IL-1beta-evuselelekileyo ye-C-28 / I2 chondrocytes. I-Osteoarthritis Cartilage 2008; 16: 1205-12. Jonga i-abstract.
62. I-Lin YC, i-Liang YC, i-Sheu MT, i-Lin YC, i-Hsieh MS, i-Chen TF, i-Chen CH. Iziphumo zeChondroprotective zeglucosamine ebandakanya i-p38 MAPK kunye ne-Akt ebonisa indlela. IRheumatol Int 2008; 28: 1009-16. Jonga i-abstract.
63. IScotto d'Abusco A, iPoliti L, iGiordano C, iScandurra R. Isiphumo se-peptidyl-glucosamine sichaphazela umsebenzi we-IKKalpha kinase kwii-chondrocyte zabantu. Isifo seArthritis Res Ther 2010; 12: R18. Jonga i-abstract.
64. I-Shikhman AR, iBrinson DC, iValbracht J, iLotz MK. Umahluko kwimiphumo ye-metabolic ye-glucosamine kunye ne-N-acetylglucosamine kwii-chondrocytes zomntu ezibalaseleyo. I-Osteoarthritis Cartilage 2009; 17: 1022-8. Jonga i-abstract.
65. Uitterlinden EJ, Koevoet JL, Verkoelen CF, Bierma-Zeinstra SM, Jahr H, Weinans H, Verhaar JA, van Osch GJ. I-Glucosamine yonyusa imveliso ye-hyaluronic acid kuphando lwe-osteoarthritic synovium. I-BMC Musculoskelet Disord 2008; 9: 120. Jonga i-abstract.
66. IHong H, iPaki YK, iChoi MS, iRyu NH, iNgoma DK, iSuh SI, iNam KY, iPaki yeGY, iJang BC. Umahluko ezantsi-kummiselo we-COX-2 kunye neMMP-13 kulusu lwefibroblast yomntu yi-glucosamine-hydrochloride. J IDermatol Sci 2009; 56: 43-50. Jonga i-abstract.
67. Wu YL, Kou YR, Ou HL, Chien HY, Chuang KH, Liu HH, Lee TS, Tsai CY, Lu ML. Ummiselo we-Glucosamine wokuvuvukala okuphakathi kwe-LPS kwiiseli ze-bronchial epithelial cell. I-Eur J Pharmacol 2010; 635 (1-3): 219-26. Jonga i-abstract.
68. Imagawa K, de Andrés MC, Hashimoto K, Pitt D, Itoi E, Goldring MB, Roach HI, Oreffo RO. Iziphumo ze-epigenetic ze-glucosamine kunye ne-nyukliya factor-kappa B (NF-kB) inhibitor kwii-chondrocyte eziphambili zabantu-iimpembelelo ze-osteoarthritis. I-Biochem Biophys Res Commun 2011; 405: 362-7. Jonga i-abstract.
69. I-Yomogida S, Kojima Y, Tsutsumi-Ishii Y, Hua J, Sakamoto K, Nagaoka I.I-Glucosamine, eyenzeka ngokwendalo i-amino monosaccharide, icinezela i-dextran sulfate sodium-indened colitis kwiigundane. I-Int J Mol Med 2008; 22: 317-23. Jonga i-abstract.
70. I-Sakai S, i-Sugawara T, i-Kishi T, i-Yanagimoto K, i-Hirata T. Iziphumo ze-glucosamine kunye nezinto ezinxulumene noko ekuthotyeni iiseli zemasti kunye nokudumba kwendlebe okubangelwa yi-dinitrofluorobenzene kwiimpuku. Ubomi beSayensi ngo-2010; 86 (9-10): 337-43. Jonga i-abstract.
71. IHwang MS, iBaek WK. I-Glucosamine induces ukufa kwesisele esizimeleyo ngokukhuthaza uxinzelelo lwe-ER kwiiseli zomhlaza we-glioma. IBiochem Biophys Res Commun 2010; 399: 111-6. Jonga i-abstract.
72. Ipaki JY, iPaki JW, iSuh SI, iBaek WK. I-D-glucosamine ezantsi-elawula i-HIF-1alpha ngokuthintela ukuguqulelwa kweprotein kwiiseli zomhlaza webala le-DU145. IBiochem Biophys Res Commun 2009; 382: 96-101. Jonga i-abstract.
73. I-Chesnokov V, i-Sun C, i-Itakura K. I-Glucosamine icinezela ukwanda kweeseli zeprostate carcinoma DU145 nge-inhibition ye-STAT3 signaling. Iseli lomhlaza Int 2009; 9:25. Jonga i-abstract.
74. Tsai CY, Lee TS, Kou YR, Wu YL. I-Glucosamine inhibit IL-1beta-Mediated IL-8 kwimveliso yeeseli zomhlaza wedlala lobudoda ngokuncitshiswa kwe-MAPK. J Iselfowuni Biochem 2009; 108: 489-98. Jonga i-abstract.
75. UKim DS, iPark KS, uJeong KC, uLee BI, uLee CH, uKim SY. I-Glucosamine sisixhobo esisebenzayo se-chemo-sensitizer nge-transglutaminase 2 inhibition. Umhlaza Lett 2009; 273: 243-9. Jonga i-abstract.
76. UNaito K, Watari T, Furuhata A, Yomogida S, Sakamoto K, Kurosawa H, Kaneko K, Nagaoka I. Uvavanyo lwesiphumo se-glucosamine kwimodeli yovavanyo lweerat osteoarthritis. Ubomi beSayensi ngo-2010; 86 (13-14): 538-43. Jonga i-abstract.
77. Weiden S kunye neWood IJ. Isiphelo se-glucosamine hydrochloride ejojowe ngaphakathi emntwini. J eKlin Pathol 1958; 11: 343-349.
78. I-Satia JA, i-Littman A, i-Slatore CG, i-Galanko JA, i-White E. Imibutho ye-herbal kunye ne-specialty supplements nge-lung kunye ne-colorectal cancer risk kwi-VITamins kunye ne-Lifestyle Study. Umhlaza we-Epidemiol Biomarkers Prev 2009; 18: 1419-28. Jonga i-abstract.
79. I-Audimoolam VK, iBhandari S. Acute nephritis yangaphakathi ebangelwa yi-glucosamine. Ukutshintshwa kweNephrol Dial 2006; 21: 2031. Jonga i-abstract.
80. Ossendza RA, Grandval P, Chinoune F, Rocher F, Chapel F, Bernardini D. [Acute cholestatic hepatitis ngenxa yeglucosamine forte]. Ikliniki ye-Gastroenterol Biol. Ngo-2007 kuMatshi; 31: 449-50. Jonga i-abstract.
81. Wu D, Huang Y, Gu Y, Fan W. Ukusebenza kwamalungiselelo ahlukeneyo e-glucosamine kunyango lwe-osteoarthritis: uhlalutyo lweemeta lwezilingo ezilawulwa ngokungekho mthethweni, ezingaboniyo, ezilawulwa yi-placebo. I-Int J Clin yokuSebenza ngo-2013; 67: 585-94. Jonga i-abstract.
82. Provenza JR, Shinjo SK, Silva JM, Peron CR, kunye noRocha FA. I-glucosamine edibeneyo kunye ne-chondroitin sulfate, kube kanye okanye kathathu imihla ngemihla, ibonelela nge-analgesia efanelekileyo yezonyango kwi-knee osteoarthritis. Iiklinikhi zeRheumatol 2015; 34: 1455-62.
83. I-Kwoh CK, i-Roemer FW, i-Hannon MJ, i-Moore CE, i-Jakicic JM, i-Guermazi A, i-Green SM, i-Evans RW, i-Boudreau R.Iziphumo ze-glucosamine yomlomo kulwakhiwo oludibeneyo kubantu abaneentlungu ezingapheliyo emadolweni. Isifo samathambo Rheumatol. Ngo-2014 kuMatshi; 66: 930-9. Jonga i-abstract.
84. von Felden J, Montani M, Kessebohm K, Stickel F.Ukulimala kwesibindi okunyanzelekileyo okuxelisa i-hepatitis emva kokutya izongezo zokutya ezine-glucosamine kunye ne-chondroitin sulfate. I-Int J Clin Pharmacol Ther 2013; 51: 219-23. Jonga i-abstract.
85. IHochberg MC, uMartel-Pelletier J, uMonfort J, uMöller I, uCastillo JR, uArden N, uBerenbaum F, uBlanco FJ, uConaghan PG, uDoménech G, uHenrotin Y, uPap T, uRichette P, uSawitzke A, uDu Souich P, uPelletier JP ; egameni leQela loPhando. Idibeneyo ye-chondroitin sulphate kunye ne-glucosamine ye-osteoarthritis ebuhlungu yamadolo: i-multicentre, i-randomized, i-blind-blind, i-non-inferiority trial kunye ne-celecoxib. UAnn Rheum Dis 2016; 75: 37-44. Jonga i-abstract.
86. ICerda C, Bruguera M, Parés A.Hepatotoxicity enxulunyaniswa ne-glucosamine kunye ne-chondroitin sulphate kwizigulana ezinesifo esinganyangekiyo sesibindi. Ihlabathi J Gastroenterol 2013; 19: 5381-4. Jonga i-abstract.
87. UFox BA, uStephens MM. I-Glucosamine hydrochloride kunyango lweempawu ze-osteoarthritis. Ukwaluphala phakathi kweKlinikhi 2007; 2: 599-604. Jonga i-abstract.
88. UVlad, S. C., LaValley, M. P., McAlindon, T., noFelson, D. T. Glucosamine wentlungu ye-osteoarthritis: kutheni iziphumo zolingo zahlukile? Rheum yeArthritis 2007; 56: 2267-2277. Jonga i-abstract.
89. Reginster, J. Y. Ukusebenza kwe-glucosamine sulphate kwi-osteoarthritis: ukungqubana kwezezimali nokungahambelani nemali. Isifo samathambo Rheum 2007; 56: 2105-2110. Jonga i-abstract.
90. UFrestedt, J. L., Walsh, M., Kuskowski, M. A., kunye noZenk, J. L. Isongezelelo sendalo sezimbiwa sinika isiqabu kwiimpawu zamadolo e-osteoarthritis: ityala lokuqhuba elingalawulwa ngokungahleliwe. Isondlo J 2008; 7: 9. Jonga i-abstract.
91. Yue, J., Yang, M., Yi, S., Dong, B., Li, W., Yang, Z., Lu, J., Zhang, R., kunye no-Yong, J. Chondroitin sulphate kunye / okanye I-glucosamine hydrochloride yesifo seKashin-Beck: isifundo esilawulwa liqela, elilawulwa yi-placebo. I-Osteoarthritis. Ngo-2012; 20: 622-629. Jonga i-abstract.
92. I-Kanzaki, N., Saito, K., Maeda, A., Kitagawa, Y., Kiso, Y., Watanabe, K., Tomonaga, A., Nagaoka, I., kunye no Yamaguchi, H. Iziphumo zesongezelelo sokutya. Equkethe i-glucosamine hydrochloride, i-chondroitin sulfate kunye ne-quercetin glycosides kwiimpawu zedolo le-osteoarthritis: isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. Ukutya okuLimo kweJ. I-3-15-2012; 92: 862-869. Jonga i-abstract.
93. UWandel, S., Juni, P., Tendal, B., Nuesch, E., Villiger, PM, Welton, NJ, Reichenbach, S., kunye noTrelle, S. Iziphumo ze-glucosamine, chondroitin, okanye i-placebo kwizigulana ezine-osteoarthritis. okhalweni okanye idolo: uhlalutyo lweemeta zenethiwekhi. BMJ 2010; 341: c4675. Jonga i-abstract.
94. ISawitzke, AD, Shi, H., Finco, MF, Dunlop, DD, Harris, CL, Singer, NG, Bradley, JD, Isilivere, D., Jackson, CG, Lane, NE, Oddis, CV, Wolfe, F. , Lisse, J., Furst, DE, Bingham, CO, Reda, DJ, Moskowitz, RW, Williams, HJ, kunye noClegg, NGOKUQINISEKISA ukusebenza konyango kunye nokhuseleko lwe-glucosamine, i-chondroitin sulphate, indibaniselwano yabo, i-celecoxib okanye i-placebo ethathiweyo ukunyanga i-osteoarthritis edolweni: Iziphumo zeminyaka emi-2 ezivela kwi-GAIT. U-Ann. Ukuhlaziya. Ngo-2010; 69: 1459-1464. Jonga i-abstract.
95. UJackson, CG, Plaas, AH, Sandy, JD, Hua, C., Kim-Rolands, S., Barnhill, JG, Harris, CL, kunye noClegg, DO I-pharmacokinetics yomntu yokufakwa ngomlomo kweglucosamine kunye ne-chondroitin sulfate ethathwe ngokwahlukeneyo okanye ngokudibeneyo. I-Osteoarthritis Cartilage 2010; 18: 297-302. Jonga i-abstract.
96. Lee, YH, Woo, J.H, Choi, S.J, Ji, J. D., kunye neNgoma, G.G.Iziphumo ze-glucosamine okanye i-chondroitin sulfate ekuqhubekeni kwe-osteoarthritis: uhlalutyo lweemeta. IRheumatol Int 2010; 30: 357-363. Jonga i-abstract.
97. I-Theoharides, T. C., Kempuraj, D., Vakali, S., kunye ne-Sant, G. R. Unyango lwe-cystitis ye-interstitial interstitial / pain pain bladder syndrome ene-CystoProtek-isongezelelo sendlela somlomo. Ngaba uJ Urol 2008; 15: 4410-4414. Jonga i-abstract.
98. I-Dudics, V., Kunstar, A., Kovacs, J., Lakatos, T., Geher, P., Gomor, B., Monostori, E., kunye no-Uher, F. I-Chondrogenic enokubakho yeeseli zeseli zemeschchal ezivela kwizigulana ezine-rheumatoid. isifo samathambo kunye ne-osteoarthritis: imilinganiselo kwinkqubo ye-microculture. Iiseli Tissue. Izixhobo 2009; 189: 307-316. Jonga i-abstract.
99. UCahlin, uB. J. noDahlstrom, L. Akukho siphumo se-glucosamine sulphate kwi-osteoarthritis kumalungu e-temporomandibular - isifundo esenziwe ngokungahleliwe, esilawulwayo, esifutshane. I-Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112: 760-766. Jonga i-abstract.
100. UShaygannejad, V., Janghorbani, M., Savoj, M. R., noAshtari, F. Iziphumo ze-adjunct glucosamine sulphate ekubuyiseleni-ekubuyiseleni phambili ukuqhubekeka kwesclerosis: iziphumo zokuqala zolingo olulawulwa ngokungekho mthethweni. I-Neurol Res 2010; 32: 981-985. Jonga i-abstract.
101. Ostojic, S. M., Arsic, M., Prodanovic, S., Vukovic, J., kunye noZlatanovic, M.Ulawulo lweGlucosamine kwiimbaleki: iziphumo ekubuyiseleni ukulimala kwamadolo. Umdlalo weRes Sports Med 2007; 15: 113-124. Jonga i-abstract.
102. Rozendaal, RM, Uitterlinden, EJ, van Osch, GJ, Garling, EH, Willemsen, SP, Ginai, AZ, Verhaar, JA, Weinans, H., Koes, BW, kunye ne-Bierma-Zeinstra, SM Iziphumo ze-glucosamine sulphate ngokudibeneyo. ukunciphisa indawo, iintlungu kunye nokusebenza kwizigulana ezine-hip osteoarthritis; uhlalutyo lwamagqabantshintshi kuvavanyo olulawulwa ngokungenamthetho. I-Osteoarthritis Cartilage 2009; 17: 427-432. Jonga i-abstract.
103. UMarti-Bonmati, L., Sanz-Requena, R., uRodrigo, uJ. L., uAlberich-Bayarri, A., noCarot, uJ. M. Glucosamine isulfate kwi-patellar cartilage eguqulweyo: iziphumo zokuqala zemodeli yemagneti ye-pharmacokinetic. I-Radiol ye-2009; 19: 1512-1518. Jonga i-abstract.
104. URovati LC, uGiacovelli G, u-Annefeld N, kunye no-al. Isifundo esikhulu, esingahleliwe, esilawulwa yi-placebo, esingaboni kabini se-glucosamine sulphate vs piroxocam kunye nomanyano lwabo kwi-kinetics yempembelelo yempawu kwi-knee osteoarthritis. Osteoarth Cartilage 1994; 2 (suppl 1): 56.
105. INandhakumar J.Ukusebenza, ukunyamezeleka, kunye nokukhuseleka kwezinto ezininzi ezinokuthintela ukuvuvukala kunye ne-glucosamine hydrochloride vs glucosamine sulphate vs i-NSAID kunyango lwe-osteoarthritis-ehleliweyo, enokwenzeka, ephindwe kabini, engaboniyo. Umdibaniso weMedin Clin J 2009; 8: 32-38.
106. UMuller-Fassbender, H., Bach, G. L., Haase, W., Rovati, L. C., kunye no-Setnikar, I. I-Glucosamine sulfate xa kuthelekiswa ne-ibuprofen kwi-osteoarthritis emadolweni. Osteoarthritis Cartilage 1994; 2: 61-69. Jonga i-abstract.
107. I-Towheed, T. E. kunye ne-Anastassiades, T. P. Unyango lwe-Glucosamine yonyango lwe-osteoarthritis. J Rheumatol 1999; 26: 2294-2297. Jonga i-abstract.
108. UZhang, W., Nuki, G., Moskowitz, RW, Abramson, S., Altman, RD, Arden, NK, Bierma-Zeinstra, S., Brandt, KD, Croft, P., Doherty, M., Dougados, M., Hochberg, M., Hunter, DJ, Kwoh, K., Lohmander, LS, kunye noTugwell, P. OARSI izindululo zolawulo lwe-hip kunye nedolo le-osteoarthritis: icandelo le-III: Utshintsho kubungqina kulandela uhlaziyo olwenziweyo lwenkqubo yophando epapashiweyo ngoJanuwari 2009. I-Osteoarthritis Cartilage 2010; 18: 476-499. Jonga i-abstract.
109. UPeteren, SG, Beyer, N., Hansen, M., Holm, L., Aagaard, P., Mackey, AL, kunye noKjaer, M. Nonsteroidal anti-inflammatory drug or glucosamine yanciphisa iintlungu kunye nokuphucula amandla emisipha ngoqeqesho lokumelana Uvavanyo olulawulwa ngokungenamthetho lwezigulana zamadolo e-osteoarthritis. IArch Phys Med Rehabil 2011; 92: 1185-1193. Jonga i-abstract.
110. UNoack, W., Fischer, M., Forster, K. K., Rovati, L. C., kunye no-Setnikar, I. I-Glucosamine sulfate kwi-osteoarthritis yamadolo. Osteoarthritis Cartilage 1994; 2: 51-59. Jonga i-abstract.
111. UGiordano N, Fioravanti A, uPapakostas P, et al. Ukusebenza kunye nokunyamezelana kwe-glucosamine sulphate kunyango lwe-osteoarthritis: ilingo elilawulwa ngokungahleliwe, elingaboniyo, elilawulwa yi-placebo. I-Curr Ther Res kwiklinikhi ye-Exp 2009; 70: 185-196. Jonga i-abstract.
112. Yamamoto, T., Kukuminato, Y., Nui, I., Takada, R., Hirao, M., Kamimura, M., Saitou, H., Asakura, K., kunye noKthethwa, A. [Ubudlelwane phakathi komungu we-birch ukungabikho komzimba kunye nomlomo kunye ne-pharyngeal hypersensitivity kwisiqhamo]. UNippon Jibiinkoka Gakkai Kaiho 1995; 98: 1086-1091. Jonga i-abstract.
113. UKawasaki T, Kurosawa H, Ikeda H, et al. Iziphumo ezongezelelekileyo zeglucosamine okanye i-risedronate kunyango lwe-osteoarthritis yedolo elidityaniswe nomsebenzi wasekhaya: ulingo lweenyanga ezili-18. J Bone Miner Metab. 2008; 26: 279-87. Jonga i-abstract.
114. UNelson BA, uRobinson KA, uBuse MG. Iswekile ephezulu kunye neglucosamine yenza ukunganyangeki kwe-insulin ngeendlela ezahlukeneyo kwi-3T3-L1 adipocytes. Iswekile 2000; 49: 981-91. Jonga i-abstract.
115. IBaron AD, iZhu JS, Zhu JH, et al. I-Glucosamine inducus ukumelana ne-insulin kwi-vivo ngokuchaphazela i-GLUT 4 translocation kwimisipha yemithambo. Iziphumo zetyhefu yeswekile. J Klinikhi yoTyalo-mali 1995; 96: 2792-801. Jonga i-abstract.
116. U-Eggertsen R, u-Andreasson A, no-Andren L. Akukho lutshintsho kumanqanaba e-cholesterol ngemveliso ye-glucosamine efumanekayo yokuthengisa kwizigulana ezinyangwa ngamachiza athoba i-lipid: isilingo esilawulwayo, esingahleliwe, esivulekileyo. I-BMCPharmacol Toxicol 2012; 13:10. Jonga i-abstract.
117. U-Liu W, uLiu G, uPei F, et al. Isifo seKashin-Beck eSichuan, China: ingxelo yokulinga evulekileyo yonyango. J Klinikhi yaseRheumatol 2012; 18: 8-14. Jonga i-abstract.
118. UNakamura H, Masuko K, Yudoh K, et al. Iziphumo zolawulo lwe-glucosamine kwizigulana ezine-rheumatoid arthritis. IRheumatol Int 2007; 27: 213-8. Jonga i-abstract.
119. UBruyere O, uPavelka K, uRovati LC, et al. Inani lilonke lokudityaniswa ngokudibeneyo emva konyango lwe-glucosamine sulphate kunyango lwe-osteoarthritis: iziphumo zokuqwalaselwa kweminyaka engama-8 yezigulana ezivela kwiminyaka emibini edlulileyo ye-3, izilingo ezilawulwa ngokungahleliwe, ezilawulwa yi-placebo. I-Osteoarthritis Cartilage 2008; 16: 254-60. Jonga i-abstract.
120. IBijlsma JWJ, iLafeber FPJG. I-Glucosamine sulfate kwi-osteoarthritis: Ijaji isaphumile. UAnn Intern Med 2008; 148: 315-6. Jonga i-abstract.
121. Rozendaal RM, Koes BW, van Osch GJVM, et al. Iziphumo ze-glucosamine sulphate kwi-hip osteoarthritis: Uvavanyo olungenamsebenzi. UAnn Intern Med 2008; 148: 268-77. Jonga i-abstract.
122. UPersiani S, uRotini R, uTrisolino G, et al. Ukuqwalaselwa kwe-Synovial kunye ne-plasma glucosamine kwizigulana ze-osteoarthritic ezilandela i-crystalline glucosamine sulphate yomlomo kunyango lwonyango. I-Osteoarthritis Cartilage 2007; 15: 764-72. Jonga i-abstract.
123. I-Yue QY, iStrandell J, i-Myrberg O. Ukusetyenziswa ngokuhambelana kweglucosamine kunokuba nefuthe le-warfarin. IZiko lokuJonga i-Uppsala. Ifumaneka apha: www.who-umc.org/graphics/9722.pdf (Ifumaneka nge-28 Epreli 2008).
124. UKnudsen J, uSokol GH. Intsingiselo yokunxibelelana kwe-glucosamine-warfarin ekhokelela kukonyuka komgangatho oqhelekileyo kwilizwe jikelele: Ingxelo yamatyala kunye nokuphononongwa koncwadi kunye nedathabheyisi yeMedWatch. I-Pharmacotherapy 2008; 28: 540-8. Jonga i-abstract.
125. UMuniyappa R, uKarne RJ, iHolo G, et al. I-Oral glucosamine yeeveki ezi-6 kwiidosi ezisemgangathweni ayibangeli okanye yenze mandundu ukunganyangeki kwe-insulin okanye ukungasebenzi kakuhle kwe-endothelial kwizifundo eziethe-ethe okanye ezityebileyo. Iswekile 2006; 55: 3142-50. Jonga i-abstract.
126. UTannock LR, Kirk EA, uKing VL, et al. Isongezelelo seGlucosamine sikhawulezisa kwangoko kodwa hayi emva kwexesha kwi-atherosclerosis kwiimpuku ezilahlekileyo ze-LDL. J Amanqatha 2006; 136: 2856-61. Jonga i-abstract.
127. UPham T, uCornea A, uBlick KE, et al. I-Oral glucosamine kwiidosi ezisetyenziselwa ukunyanga i-osteoarthritis kuyenza mandundu ukunganyangeki kwe-insulin. NdinguJ Med Sci 2007; 333: 333-9. Jonga i-abstract.
128. UMessier SP, uMihalko S, uLoeser RF, et al. I-Glucosamine / chondroitin edityaniswe nokuzivocavoca kunyango lwe-osteoarthritis: isifundo sokuqala. I-Osteoarthritis Cartilage 2007; 15: 1256-66. Jonga i-abstract.
129. IStumpf JL, iLin SW. Iziphumo zeglucosamine kulawulo lweglucose. UAnn Pharmacother 2006; 40: 694-8. Jonga i-abstract.
130. UBush TM, uRayburn KS, uHolloway SW, et al.Ukudibana okungalunganga phakathi kwezinto zemifuno kunye nokutya kunye namayeza amiselweyo: kuvavanyo lweklinikhi. Enye indlela yoNyango lwezeMpilo ngo-2007; 13: 30-5. Jonga i-abstract.
131. I-Towheed TE, uMaxwell L, uAnastassiades TP, et al. Unyango lweGlucosamine yokunyanga i-osteoarthritis. Isiseko sedatha yeCochrane Sy Rev Rev 2005;: CD002946. Jonga i-abstract.
132. Poolsup N, Suthisisang C, Channark P, Kittikulsuth W. Glucosamine unyango lwexesha elide kunye nokuqhubela phambili kweedolo osteoarthritis: uphononongo olucwangcisiweyo lwezilingo ezilawulwa ngokungahleliwe. UAnn Pharmacother 2005; 39: 1080-7. Jonga i-abstract.
133. I-Qiu GX, iWeng XS, uZhang K, et al. [Uvavanyo oluninzi oluphakathi, olungenamkhethe, olulawulwayo lonyango lwe-glucosamine hydrochloride / sulphate kunyango lwe-osteoarthritis]. UZhonghua Yi Xue Za Zhi 2005; 85: 3067-70. Jonga i-abstract.
134. UClegg DO, uReda DJ, uHarris CL, et al. I-Glucosamine, i-chondroitin sulphate, kwaye zombini zidityanisiwe zedolo osteoarthritis. N Engl J Med 2006; 354: 795-808. Jonga i-abstract.
135. IHerrero-Beaumont G, i-Ivorra JA, iDel Carmen Trabado M, et al. I-Glucosamine sulfate kunyango lweempawu zamadolo e-osteoarthritis: isifundo esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo sisebenzisa i-acetaminophen njengothelekiso osecaleni. Isifo samathambo Rheum 2007; 56: 555-67. Jonga i-abstract.
136. I-Theodosakis J. Uvavanyo olulawulwa ngokungekho mthethweni, oluyimfama kabini, olulawulwa yi-placebo lwekhrim ye-cream equkethe i-glucosamine sulfate, i-chondroitin sulfate, kunye ne-camphor ye-osteoarthritis emadolweni. J Rheumatol 2004; 31: 826. Jonga i-abstract.
137. UZhang W, uDoherty M, uArden N, et al. Ubungqina be-EULAR obusekwe kwizindululo kulawulo lwe-hip osteoarthritis: ingxelo yeqela elisebenzayo leKomiti eSisigxina ye-EULAR yeZifundo zeKlinikhi yaMazwe ngaMazwe kubandakanya i-Therapeutics (ESCISIT). UAnn Rheum Dis 2005; 64: 669-81. Jonga i-abstract.
138. I-Towheed TE, i-Anastassiades TP, uShea B, et al. Unyango lweGlucosamine yokunyanga i-osteoarthritis. Isiseko sedatha yeCochrane Sy Rev Rev 2001; 1: CD002946. Jonga i-abstract.
139. UMcAlindon T. Kutheni izilingo zeklinikhi ye-glucosamine ingasasebenzi ngokufanayo? Rheum Dis Clin eMantla Am 2003; 29: 789-801. Jonga i-abstract.
140. UCibere J, uKopec JA, uTrne A, et al. Ukuvavanywa kokuyekiswa kokuvavanywa okungafunekiyo, okungaboniyo kabini, kweglucosamine kwi-knee osteoarthritis. Isifo samathambo Rheum 2004; 51: 738-45. Jonga i-abstract.
141. UMcAlindon T, uFomica M, uLaValley M, et al. Ukusebenza kweglucosamine yeempawu zamadolo e-osteoarthritis: iziphumo ezivela kwi-intanethi esekwe kwilingo elilawulwa ngokungekho mthethweni. NdinguJ Med 2004; 117: 643-9. Jonga i-abstract.
142. UBruyere O, uPavelka K, uRovati LC, et al. I-Glucosamine sulfate inciphisa ukuqhubela phambili kwe-osteoarthritis kubafazi be-postmenopausal abanedolo le-osteoarthritis: ubungqina obuvela kwizifundo ezibini ezineminyaka emi-3. Ukuya exesheni ngo-2004; 11: 138-43. Jonga i-abstract.
143. Ngwevu HC, Hutcheson PS, Slavin RG. Ngaba i-glucosamine ikhuselekile kwizigulana ezinokutya kwaselwandle (ileta)? J Ikliniki ye-Allergy Immunol 2004; 114: 459-60. Jonga i-abstract.
144. UTannis AJ, uBarban J, uMoyise uJ. Iziphumo zokuncedisa i-glucosamine ekuzileni nasekungayidliyo i-plasma glucose kunye ne-serum insulin egxile kubantu abasempilweni. I-Osteoarthritis Cartilage 2004; 12: 506-11. Jonga i-abstract.
145. UWeimann G, uLubenow N, uSelleng K, et al. I-Glucosamine sulphate ayidibani ne-antibodies yezigulana ezine-heparin-induced thrombocytopenia. I-Eur J Haematol 2001; 66: 195-9. Jonga i-abstract.
146. I-Hughes R, uCarr A. Uvavanyo olulawulwa ngokungahleliwe, oluyimfama, olulawulwa yi-placebo lwe-glucosamine sulphate njenge-analgesic kwi-osteoarthritis emadolweni. IRheumatology (Oxford) 2002; 41: 279-84. . Jonga i-abstract.
147. Rozenfeld V, iCrain JL, uCallahan AK. Ukonyusa okunokwenzeka kwimpembelelo ye-warfarin yi-glucosamine-chondroitin. NdinguJ J Health Syst Pharm 2004; 61: 306-307. Jonga i-abstract.
148. Ukuthotywa kweTE. Imeko yangoku yonyango lwe-glucosamine kwi-osteoarthritis. Isifo samathambo Rheum 2003; 49: 601-4. Jonga i-abstract.
149. Ilungu lePalamente laseGuillaume, uPeretz A.Umanyano olunokwenzeka phakathi konyango lwe-glucosamine kunye netyhefu yezintso: ukubeka izimvo kwileta nguDanao-Camara. Isifo samathambo Rheum 2001; 44: 2943-4. Jonga i-abstract.
150. UDanao-Camara T.Iziphumo ebezingalindelekanga zonyango kunye ne-glucosamine kunye ne-chondroitin. Isifo samathambo Rheum 2000; 43: 2853. Jonga i-abstract.
151. U-Cohen M, u-Wolfe R, u-Mai T, u-Lewis D. Uvavanyo olungahleliwe, oluyimfama, olulawulwa yi-placebo lwekhrimu ye-cream ene-glucosamine sulfate, i-chondroitin sulphate, kunye ne-camphor ye-osteoarthritis emadolweni. J Rheumatol 2003; 30: 523-8 .. Jonga i-abstract.
152. U-Yu JG, ii-Boies SM, i-Olefsky JM. Iziphumo ze-glucosamine sulphate yomlomo kwimvakalelo ye-insulin kwizifundo zabantu. Unonophelo lweSwekile 2003; 26: 1941-2. Jonga i-abstract.
153. I-Setnikar I, iRovati LC. Ukufunxa, ukuhanjiswa, imetabolism kunye nokukhutshwa kweglucosamine sulphate. Uphengululo. IArzneimittelforschung 2001; 51: 699-725. Jonga i-abstract.
154. IHoffer LJ, uKaplan LN, uHamadeh MJ, et al. I-Sulfate inokulamla kwisiphumo sonyango lwe-glucosamine sulphate. IMetabolism 2001; 50: 767-70 .. Jonga i-abstract.
155. UBraham R, uDawson B, uGoodman C. Iziphumo zokuxhaswa kweglucosamine kubantu abafumana iintlungu zedolo rhoqo. Br J Ezemidlalo Med 2003; 37: 45-9. Jonga i-abstract.
156. IScroggie DA, Albright A, Harris MD. Iziphumo zokuxhaswa kwe-glucosamine-chondroitin kumanqanaba e-hemoglobin eglycosylated kwizigulana ezinesifo seswekile seswekile: i-placebo elawulwa yi-placebo, eyimfama ephindwe kabini, yolingo olungenamkhethe. IArch Intern Med 2003; 163: 1587-90. Jonga i-abstract.
157. URichy F, uBruyere O, uEtgen O, et al. Ulwakhiwo kunye nokusebenza kweempawu zeglucosamine kunye ne-chondroitin kwiedolo osteoarthritis: uhlalutyo olubanzi lweemeta. IArch Intern Med 2003; 163: 1514-22. Jonga i-abstract.
158. USalvatore S, uHeuschkel R, uTomlin S, et al. Isifundo somqhubi wenqwelo moya se-N-acetyl glucosamine, isiseko sesondlo se-glycosaminoglycan synthesis, kwizigulo ezinganyangekiyo kwizifo zamathumbu ezingapheliyo. I-Aliment Pharmacol Ther 2000; 14: 1567-79 .. Jonga i-abstract.
159. Tallia AF, Cardone DA. Ukuqaqanjelwa sisifuba okunxulunyaniswa neglucosamine-chondroitin supplement. J IBhodi yeBhodi Fam Pract 2002; 15: 481-4 .. Jonga i-abstract.
160. UTiku ML, uNarla H, uKarry SK, et al. I-Glucosamine Inhibits Advanced Lipoxidation Reaction kunye noHlengahlengiso lweeKhemikhali zeLipoproteins nguScrivenging Reactive Carbonyl Intermediates. Ikholeji yaseMelika yeNtlanganiso yeRheumatology; Okthobha 25-29, 2002. Abstract 11.
161. UAlvarez-Soria MA, uLargo R, uDiez-Ortego E, okqhubekayo. I-Glucosamine inhibits IL-1ß-indved NF-kappa B yovulo kwi-Human Osteoarthritic chondrocytes. Ikholeji yaseMelika yeNtlanganiso yeRheumatology; Okthobha 25-29, 2002. Abstract 118.
162. UGanu VA, uHu SI, uStrassman J, et al. I-inhibitors ze-N-glycosylation Nciphisa ukuveliswa kweCytokine ye-Matrix Metalloproteinases, i-Nitric oxide, kunye ne-PGE2 kwi-Articular Chondrocytes: Inkqubo yoMgqatswa yeZiphumo zeChondroprotective ze-d-Glucosamine. Ikholeji yaseMelika yeNtlanganiso yeRheumatology; Okthobha 25-29, 2002. Abstract 616.
163. UDu XL, uEdelstein D, uDimmeler S, et al. I-Hyperglycemia inqanda i-endothelial nitric oxide synthase ye-post-translational modification kwisiza seAkt. J Iklinikhi yokuTyala ngo-2001; 108: 1341-8. Jonga i-abstract.
164. UPavelka K, uGatterova J, uOlejarova M, et al. Ukusetyenziswa kwe-Glucosamine sulphate kunye nokulibaziseka kokuqhubela phambili kwamadolo e-osteoarthritis: Unyaka we-3, olawulwa yi-placebo, olawulwa yi-placebo, ongaboniyo kabini. IArch Intern Med 2002; 162: 2113-23. Jonga i-abstract.
165. IAdebowale AO, iCox DS, uLiang Z, et al. Uhlalutyo lwe-glucosamine kunye nomxholo we-chondroitin sulphate kwiimveliso ezithengisiweyo kunye nokuqina kweCaco-2 kwezinto ze-chondroitin sulfate. UJANA 2000; 3: 37-44.
166. I-Bagasra O, i-Whittle P, i-Heins B, iPomerantz RJ. Uhlobo lwe-virus ye-anti-human immunodeficiency yohlobo lwe-1 lomsebenzi we-monosaccharides enesulfate: ukuthelekisa kunye ne-polysaccharides enesulfate kunye nezinye iipoliyoni. J Ukuchaphazela iDis 1991; 164: 1082-90. Jonga i-abstract.
167. Ngoku u-A, Szczesniak L, Rychlewski T, et al. Amanqanaba eglucosamine kubantu abanesifo sentliziyo eseschemic kunye nangaphandle kohlobo lwesibini lweswekile. Ipolisi yeArch Med Wewn 1998; 100: 419-25. Jonga i-abstract.
168. I-Olszewski AJ, iSzostak WB, iMcCully KS. IPlasma glucosamine kunye negalactosamine kwisifo sentliziyo eschemic. I-Atherosclerosis 1990; 82: 75-83. Jonga i-abstract.
169. U-Yun J, u-Tomida A, u-Nagata K, u-Tsuruo T. Uxinzelelo lwe-Glucose-ukumelana noxinzelelo lwe-VP-16 kwiiseli zomhlaza womntu ngokuhla kwe-DNA topoisomerase II. I-Oncol Res 1995; 7: 583-90. Jonga i-abstract.
170. I-Pouwels MJ, uJacobs JR, iSpan PN, et al. Ukufakwa kwe-glucosamine yexesha elifutshane akuchaphazeli uvakalelo lwe-insulin ebantwini. J Ikliniki ye-Endocrinol Metab 2001; 86: 2099-103. Jonga i-abstract.
171. UMonauni T, uZenti MG, uCretti A, et al. Iziphumo zokufakwa kwe-glucosamine kwimfihlo ye-insulin kunye nesenzo se-insulin ebantwini. Iswekile 2000; 49: 926-35. Jonga i-abstract.
172. I-Das A Jr, iHammad TA. Ukusebenza kwendibaniselwano ye-FCHG49 glucosamine hydrochloride, TRH122 ephantsi yemolekyuli yesodium chondroitin sulphate kunye ne-manganese ascorbate kulawulo lweedolo osteoarthritis. I-Osteoarthritis Cartilage 2000; 8: 343-50. Jonga i-abstract.
173. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukungeniswa kwereferensi yokutya kwiVitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, kunye neZinc. IWashington, DC: ICandelo leSizwe lezeMfundo, 2002. Iyafumaneka kwi: www.nap.edu/books/0309072794/html/.
174. Ngaba i-glucosamine inyusa amanqanaba e-serum lipid kunye noxinzelelo lwegazi? Ileta ka-Pharmacist / I-Prescriber's Letter 2001; 17: 171115.
175. Reginster JY, Deroisy R, Rovati LC, et al. Iziphumo zexesha elide zeglucosamine sulphate ekuqhubekeni kwe-osteoarthritis: ulingo olulawulwa ngokungekho mthethweni, olulawulwa yi-placebo. ILancet 2001; 357: 251-6. Jonga i-abstract.
176. IAlmada A, uHarvey P, uPlatt K. Iziphumo zesifo esinganyangekiyo somlomo we-glucosamine sulfate kwi-index ye-insulin yokuxhathisa isalathiso (i-FIRI) kubantu abangenasifo seswekile. I-FASEB J 2000; 14: A750.
177. I-Leffler CT, iPhilippi AF, iLeffler SG, et al. I-Glucosamine, i-chondroitin, kunye ne-manganese ascorbate yezifo ezidibeneyo zokudodobala kwedolo okanye umva ophantsi: isifundo somqhubi esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. IMil Med 1999; 164: 85-91. Jonga i-abstract.
178. Thie NM, Prasad NG, Major PW. Uvavanyo lwe-glucosamine sulphate xa kuthelekiswa ne-ibuprofen kunyango lwe-temporomandibular ngokudibeneyo ye-osteoarthritis: ilingo elingenamkhethe eliphindwe kabini elilawulwa lilingo leenyanga ezi-3. UJ Rheumatol 2001; 28: 1347-55. Jonga i-abstract.
179. UShankar RR, uZhu JS, uBaron AD. Ukufakwa kwe-Glucosamine kwiigundane kuxelisa ukungasebenzi kakuhle kwe-beta-cell yesifo seswekile esingaxhomekekanga kwi-insulin. Imetabolism 1998; 47: 573-7. Jonga i-abstract.
180. URossetti L, uHawkins M, uChen W, et al. Kwi-vivo glucosamine infusion induces insulin insulin in normoglycemic kodwa hayi kwiigundane ezazi kakuhle. J Klinikhi yoTyalo-mali 1995; 96: 132-40. Jonga i-abstract.
181. IBurton AF, kunye noAnderson FH. Ukuncipha kokudityaniswa kwe-14C-glucosamine xa kuthelekiswa ne-3H-N-acetyl glucosamine kwi-mucosa yamathumbu kwizigulana ezinesifo sokudumba. NdinguJ Gastroenterol 1983; 78: 19-22. Jonga i-abstract.
182. IBarclay TS, iTsourounis C, iMcCart GM. Iswekile yeglucosamine. UAnn Pharmacother 1998; 32: 574-9. Jonga i-abstract.
183. USetnikar I, uPalumbo R, uCanali S, et al. I-Pharmacokinetics yeglucosamine emntwini. IArzneimittelforschung 1993; 43: 1109-13. Jonga i-abstract.
184. UForster K, uSchmid K, uRovati L, et al. Unyango lwexesha elide lwe-osteoarthritis emnene ukuya kumodareyini yedolo kunye ne-glucosamine sulphate- isifundo esilawulwa ngokungahleliwe, esingaboniyo sonyango. I-Eur J Clin Pharmacol 1996; 50: 542 (PubMed) (Umnqamlezo)
185. I-Reichelt A. Ukusebenza kunye nokukhuseleka kwe-intramuscular glucosamine sulphate kwi-osteoarthritis yedolo. Isifundo esilawulwa ngokungahleliwe, esilawulwa yi-placebo, esingaboni kabini. IArzneimittelforschung 1994; 44: 75-80. Jonga i-abstract.
186. Qiu GX, Gao SN, Giacovelli G, et al. Ukusebenza kunye nokhuseleko lwe-glucosamine sulphate xa ithelekiswa ne-ibuprofen kwizigulana ezinedolo le-osteoarthritis. IArzneimittelforschung 1998; 48: 469-74. Jonga i-abstract.
187. IPujjalte JM, iLlavore EP, iYlescupidez FR. Uvavanyo lweklinikhi olungaboni kabini ngomlomo we-glucosamine sulphate kunyango olusisiseko lwe-osteoarthrosis. I-Curr Med Res Opin ngo-1980; 7: 110-4. Jonga i-abstract.
188. I-Lopes Vaz A. Imfama kabini, kuvavanyo lweklinikhi yokuhambelana nokusebenza kwe-ibuprofen kunye ne-glucosamine sulphate kulawulo lwe-osteoarthrosis yamadolo kwizigulana ezingaphandle. ICurr Med Res Opin ngo-1982; 8: 145-9. Jonga i-abstract.
189. I-da Camara CC, i-GV engenamsebenzi. I-Glucosamine sulfate ye-osteoarthritis. UAnn Pharmacother 1998; 32: 580-7. Jonga i-abstract.
190. UDrovanti A, uBignamini AA, uRovati AL. Umsebenzi wonyango we-glucosamine sulphate yomlomo kwi-osteoarthrosis: uphando olulawulwa yi-placebo olulawulwa kabini. Iiklinikhi zeTher 1980; 3: 260-72. Jonga i-abstract.
191. UMcAlindon TE, iLungu lePalamente yeLaValley, iGulin JP, uFelson DT. I-Glucosamine kunye ne-chondroitin kunyango lwe-osteoarthritis: uvavanyo lomgangatho olucwangcisiweyo kunye nohlalutyo lwe-meta. IJAMA 2000; 283: 1469-75. Jonga i-abstract.
192. IHupt JB, McMillan R, Wein C, iPaget-Dellio SD. Iziphumo ze-glucosamine hydrochloride kunyango lwentlungu ye-osteoarthritis yedolo. UJ Rheumatol 1999; 26: 2423-30. Jonga i-abstract.
193. URindone JP, uHiller D, uCollacott E, et al. Uvavanyo olungenamda, olulawulwayo lwe-glucosamine yokunyanga i-osteoarthritis emadolweni. INtshona J Med 2000; 172: 91-4. Jonga i-abstract.
194. UFosterster KK, uSchmid K, uRovati LC. Ukusebenza kweglucosamine sulphate kwi-osteoarthritis yomqolo we-lumbar: isifundo esilawulwa yi-placebo, esingahleliwe, esingaboniyo kabini. NdinguColl Rheumatol 64th Ann Scientific Mtg, Philadelphia, PA: 2000; Okt 29- Novemba 2: abstract 1613.
195. UKim YB, uZhu JS, uZierath JR, et al. Ukufakwa kwe-Glucosamine kwiigundane kuyaphazamisa ngokukhawuleza ukukhuthaza i-insulin ye-phosphoinositide 3-kinase kodwa ayitshintshi ukwenziwa kwe-Akt / protein kinase B kwimisipha yamathambo. Iswekile 1999; 48: 310-20. Jonga i-abstract.
196. IHolmang A, uNilsson C, uNiklasson M, et al. Ukwenziwa kokuchasana kwe-insulin yi-glucosamine kunciphisa ukuhamba kwegazi kodwa hayi amanqanaba e-glucose okanye i-insulin. Iswekile 1999; 48: 106-11. Jonga i-abstract.
197. UGiaccari A, uMorviducci L, uZorretta D, okqhubekayo. Kwiziphumo ze-vivo ze-glucosamine kwimfihlo ye-insulin kunye nobuntununtunu be-insulin kumgangatho: kunokwenzeka ukubaluleka kweempendulo ze-maladaptive kwi-hyperglycaemia engapheliyo. Iswekile 1995; 38: 518-24. Jonga i-abstract.
198. IBalkan B, Dunning BE. I-Glucosamine inqanda i-glucokinase in vitro kwaye ivelise ukonakala okuthile kwe-glucose kwi-vivo insulin secretion kwiigundane. Iswekile 1994; 43: 1173-9. Jonga i-abstract.
199. Adams ME. Uhlobo malunga ne-glucosamine. ILancet 1999; 354: 353-4. Jonga i-abstract.

Ukuhlaziywa okokugqibela-03/03/2021